Nature Biotechnology · 2024 · 13 citations · 34 references
PharmacyMedicinal ChemistryPharmacologyDrug DeliveryMolecular PharmacologyProdrug DesignAntioxidant DefenseOxidative StressOxidative Stress MechanismsReactive Oxygen SpeciesReactive Oxygen Species-responsive Drug DeliveryRedox-activated ProdrugsAntioxidant PharmacologyBaeyer-villiger OxidationNrf2 Pathway ActivationNrf2 Signaling PathwayProdrug Release MechanismsReactive Oxygen Species-triggered ProdrugsSite-selective Drug ReleaseSystemic Adverse Effects
Treatment of diseases of oxidative stress through activation of the antioxidant nuclear factor E2-related factor 2 (NRF2) is limited by systemic side effects. We chemically functionalize the NRF2 activator monomethyl fumarate to require Baeyer–Villiger oxidation for release of the active drug at sites of oxidative stress. This prodrug reverses chronic pain in mice with reduced side effects and could be applied to other disorders of oxidative stress. Peroxides localized at oxidative stress sites trigger prodrug release for treating chronic pain in mice.
34
Theo Vos, Stephen S Lim, Cristiana Abbafati et al. · The Lancet · 2020 · 19.2K citations · Full text
Quantitative assessment of tactile allodynia in the rat paw
Sandra R. Chaplan, Flemming W. Bach, J W Pogrel et al. · Journal of Neuroscience Methods · 1994 · 7.9K citations
Spared nerve injury: an animal model of persistent peripheral neuropathic pain
Isabelle Décosterd, Clifford J. Woolf · Pain · 2000 · 2.3K citations
Medicine, Neurology, Neuroscience +16